3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vasculitis, Central Nervous System
1
Stiff-Person Syndrome
1
Rasmussen subacute encephalitis
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Plasmablastic Lymphoma
1
Opsoclonus-Myoclonus Syndrome
1
Neuromyelitis Optica
1
Myasthenia Gravis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lambert-Eaton Myasthenic Syndrome
1
Hodgkin Disease
1
HIV Infections
1
Burkitt Lymphoma
1
Brain Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
Bexarotene
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
carmustine, poliferprosan 20 drug combination
×
1 year
×
Clear all
No trials found.